|
|
|
|
Here is a list of diseases for which stem cell treatment has been used:
|
Acute Leukemias
Acute Biphenotypic Leukemia
Acute Lymphocytic Leukemia (ALL)
Acute Myelogenous Leukemia (AML)
Acute Undifferentiated Leukemia
Chronic Leukemias
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelogenous Leukemia (CML)
Juvenile Chronic Myelogenous Leukemia (JCML)
Juvenile Myelomonocytic Leukemia (JMML)
Myelodysplastic Syndromes
Amyloidosis
Chronic Myelomonocytic Leukemia (CMML)
Refractory Anemia (RA)
Refractory Anemia with Excess Blasts (RAEB)
Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
Refractory Anemia with Ringed Sideroblasts (RARS)
Stem Cell Disorders
Aplastic Anemia (Severe)
Congenital Cytopenia
Dyskeratosis Congenita
Fanconi Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myeloproliferative Disorders
Acute Myelofibrosis
Agnogenic Myeloid Metaplasia (Myelofibrosis)
Essential Thrombocythemia
Polycythemia Vera
Lymphoproliferative Disorders
Hodgkin's Disease
Non-Hodgkin's Lymphoma
Prolymphocytic Leukemia
|
Liposomal Storage Diseases
Adrenoleukodystrophy
Alpha Mannosidosis
Gaucher's Disease
Hunter's Syndrome (MPS-II)
Hurler's Syndrome (MPS-IH)
Krabbe Disease
Maroteaux-Lamy Syndrome (MPS-VI)
Metachromatic Leukodystrophy
Morquio Syndrome (MPS-IV)
Mucolipidosis II (I-cell Disease)
Mucopolysaccharidoses (MPS)
Niemann-Pick Disease
Sanfilippo Syndrome (MPS-III)
Scheie Syndrome (MPS-IS)
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
Wolman Disease
Histiocytic Disorders
Familial Erythrophagocytic Lymphohistiocytosis
Hemophagocytosis
Histiocytosis-X
Langerhans' Cell Histiocytosis
Inherited Erythrocyte Abnormalities
Beta Thalassemia Major
Blackfan-Diamond Anemia
Pure Red Cell Aplasia
Sickle Cell Disease
Congenital (Inherited) Immune System Disorders
Absence of T and B Cells SCID
Absence of T Cells, Normal B Cell SCID
Ataxia-Telangiectasia
Bare Lymphocyte Syndrome
Common Variable Immunodeficiency
DiGeorge Syndrome
Kostmann Syndrome
Leukocyte Adhesion Deficiency
Omenn's Syndrome
Severe Combined Immunodeficiency (SCID)
SCID with Adenosine Deaminase Deficiency
Wiskott-Aldrich Syndrome
X-Linked Lymphoproliferative Disorder
|
Other Inherited Disorders
Cartilage-Hair Hypoplasia
Ceroid Lipofuscinosis
Congenital Erythropoietic Porphyria
Glanzmann Thrombasthenia
Lesch-Nyhan Syndrome
Osteopetrosis
Sandhoff Disease
Inherited Platelet Abnormalities
Amegakaryocytosis / Congenital Thrombocytopenia
Plasma Cell Disorders
Multiple Myeloma
Plasma Cell Leukemia
Waldenstrom's Macroglobulinemia
Other Malignancies
Brain Tumors
Ewing Sarcoma
Neuroblastoma
Ovarian Cancer
Renal Cell Carcinoma
Small-Cell Lung Cancer
Testicular Cancer
Autoimmune Diseases
Multiple Sclerosis (experimental)
Rheumatoid Arthritis (experimental)
Systemic Lupus Erythematosus (experimental)
Emerging Stem Cell Applications*
Alzheimer's Disease
Diabetes
Heart Disease
Liver Disease
Muscular Dystrophy
Parkinson's Disease
Spinal Cord Injury
Stroke
Phagocyte Disorders
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
Neutrophil Actin Deficiency
Reticular Dysgenesis
|
|
* Chen, Jieli, et al. Expression of neural markers in human umbilical cord blood.
Experimental Neurology.2001;171:109-115
*Pessina, A., et al. Pancreas developing
markers expressed on human mononucleated umbilical cord blood cells. Biochemical
and Biophysical Research Communications.2004;323:315-322
*Botta, Rosanna, et al.
Heart infarct in NOD-SCID mice: Therapeutic vasculogenesis by transplantation of
human CD34+ cells and low dose CD34+KDR+cells. The FASEB Journal.2004;18:1392-1394
*Perin, E., et al. Transendocardial, autologous bone marrow cell transplantation
for severe, chronic ischemic heart failure. Circulation.2003;107:2294-2302
*Campli,
C., et al. A human umbilical cord stem cell rescue therapy in a murine model of
toxic liver injury. Digestive and Liver Disease.2004;36:603-613
*Gussoni, E., et
al. Long term persistence of donor nuclei in a duchenne muscular dystrophy patient
receiving bone marrow transplantation. The Journal of Clinical Investigation.2002;110(6):807-814
*Saporta, Samuel, et al. Human umbilical cord blood stem cells infusion in spinal
cord injury: Engraftment and beneficial influence on behavior. Journal of Hematotherapy
& Stem Cell Research.2003;12:271-278
*Vendrame, Martina, et al. Infusion of human
umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral
deficits and reduces infarct volume. Stroke.2004;35:2390-2395.